Comparative Analysis of Untargeted and Targeted Lipidomics

Lipidomics investigates the diversity, functional dynamics, and biological significance of lipid species within living systems. Based on methodological frameworks and research objectives, this field bifurcates into two paradigms: Untargeted Lipidomics (hypothesis-generating) and Targeted Lipidomics (hypothesis-driven). These approaches diverge markedly in their conceptual frameworks, analytical objectives, technological requirements, and sample preparation methodologies, while sharing foundational principles in lipid characterization. This comparative evaluation delineates their distinct advantages, limitations, and synergistic roles in advancing lipid research, providing researchers with actionable insights to select context-appropriate strategies.

Learn more: Lipidomics: A Comprehensive Overview

Targeted and non-targeted analysis in lipidomics (Triebl A et al., 2017).

Conceptual Contrast

Untargeted Lipidomics

Conceptual Framework

Untargeted lipidomics employs a holistic analytical strategy to profile the complete lipid repertoire within biological specimens. Utilizing high-resolution mass spectrometry coupled with chromatographic separation, this hypothesis-free approach systematically identifies and quantifies lipid species without prior selection of targets. It serves as a discovery tool to map lipid diversity, uncover novel metabolic pathways, and elucidate lipid functional networks across biological systems.

Distinctive Attributes

• Comprehensive Profiling: Enables detection of both known and uncharacterized lipid species across all major classes (e.g., glycerolipids, sphingolipids), revealing systemic lipidomic alterations.
• High-Throughput Capacity: Advanced instrumentation facilitates simultaneous analysis of thousands of lipids, generating expansive datasets for exploratory research.
• Discovery Potential: Identifies candidate biomarkers and unknown lipid-protein interactions, particularly in pathological or stress-induced states.
• Computational Intensity: Requires sophisticated bioinformatics pipelines for peak alignment, annotation, and multivariate analysis to manage dataset complexity.
• Broad Applicability: Extends to disease mechanism studies, environmental toxicology, and nutritional science, supporting hypothesis generation in diverse contexts.

If you want to know more about non-targeting, please see "Overview of Untargeted Lipidomics".

Targeted Lipidomics

Conceptual Framework

Targeted lipidomics adopts a hypothesis-driven methodology, focusing on precise quantification of predefined lipid panels. Leveraging techniques such as Multiple Reaction Monitoring (MRM), this approach prioritizes analytical rigor for specific lipid classes or molecules, delivering absolute quantification via internal standards. It is optimized for validating biomarkers, monitoring metabolic fluxes, and assessing therapeutic interventions.

Distinctive Attributes

• Analytical Precision: Achieves sub-nanomolar sensitivity for low-abundance lipids (e.g., signaling mediators like ceramides or eicosanoids).
• Selective Detection: Utilizes transition-specific MS/MS parameters to minimize matrix interference, ensuring high specificity.
• Quantitative Rigor: Employs isotopically labeled standards for accurate concentration determination, enabling longitudinal tracking of lipid dynamics.
• Operational Efficiency: Reduced data complexity lowers computational demands, streamlining analysis for high-sample-throughput studies.
• Clinical Utility: Validated protocols support diagnostic applications, drug efficacy trials, and personalized medicine through reproducible lipid quantification.

Comparison of Technical Principles

Untargeted Lipidomics

Core Analytical Framework

Untargeted lipidomics relies on high-resolution mass spectrometers (HRMS) or liquid chromatography-mass spectrometry (LC-MS) platforms, integrated with expansive lipid repositories (e.g., LipidMaps, HMDB) for comprehensive molecular profiling. This approach enables systematic detection of lipid species without prior selection, facilitating discovery of novel metabolites and metabolic networks.

Instrumentation and Resolution

• High-Resolution Mass Spectrometry: Instruments such as the Orbitrap Fusion Lumos (Thermo Fisher) achieve resolutions exceeding 120,000 FWHM with sub-1 ppm mass accuracy, enabling differentiation of near-isobaric species (e.g., C16:0 vs. C18:0 fatty acid sidechains).
• Data Acquisition Modes:
  • Full-spectrum scanning (m/z 50–2000) captures global lipid signatures.
  • Data-dependent acquisition (DDA) prioritizes fragmentation of the most abundant ions (Top N) to enhance structural elucidation.
• Ionization Techniques:
  • Electrospray ionization (ESI) optimizes detection of polar lipids (phosphatidylcholines, sphingomyelins).
  • Atmospheric pressure chemical ionization (APCI) excels for nonpolar species (cholesteryl esters, triacylglycerols).

Chromatographic Separation

• C18 reversed-phase columns with gradient elution (e.g., acetonitrile/water + 0.1% formic acid) resolve isomeric lipids (e.g., PC 34:1 vs. PC 36:1).
• Hydrophilic interaction liquid chromatography (HILIC) partitions strongly polar lipids (lysophosphatidic acids).

Data Annotation and Resources

• Reference databases like LipidMaps (containing >400,000 lipid entries) standardize nomenclature (e.g., PC 16:0_18:1 for sn-1 and sn-2 acyl chains).
• HMDB integrates metabolic pathway correlations, supporting functional analysis.

Workflow Overview

• Sample Preparation: Total lipid extraction (Folch/MTBE methods) coupled with deproteinization.
• LC-MS/MS Analysis: Dual detection of precursor and fragment ions.
• Data Processing:
  • Retention time and m/z alignment via tools like XCMS Online.
  • Structural annotation using spectral libraries and diagnostic fragments (e.g., m/z 184 for phosphatidylcholines).
  • Isomer discrimination via collision cross-section (CCS) databases or ion mobility spectrometry (IMS).

Critical Challenges

• Isomer Complexity: Structural analogs (e.g., DG 34:1 vs. TG 34:1) necessitate advanced separation and CCS validation.
• Database Gaps: ~30% of lipids lack reference standards, particularly novel ether-linked phospholipids.
• Dynamic Range Limitations: High-abundance lipids (e.g., triglycerides) may obscure low-concentration species (e.g., ceramides), requiring signal optimization strategies.

Targeted Lipidomics

Core Analytical Technologies

Targeted lipidomics employs selective or parallel reaction monitoring (SRM/MRM or PRM) methodologies, typically integrated with triple quadrupole (QQQ) or high-resolution mass spectrometers. These platforms enable precise quantification of predefined lipid species through optimized analytical workflows.

Ion Transition Strategies

• SRM/MRM: Specific precursor-to-product ion transitions (e.g., m/z 780→184 for PC 16:0/18:1) are selected to isolate target signals while filtering background noise via QQQ filtration.
• Dynamic Range Adaptation: Segmented scanning (e.g., 1 pg/mL–1 μg/mL) accommodates broad concentration ranges, ensuring sensitivity across varying abundance levels.

Schematic diagram of the multiplexed NPLC/HILIC-QqQ lipidomics setup (Zhang NR et al., 2022).

High-Resolution PRM

Orbitrap-based PRM concurrently monitors fragment ions of multiple lipids (e.g., SM d18:1/16:0 and SM d18:1/18:0), leveraging high mass accuracy for unambiguous identification.

Quantification Standards and Calibration

• Isotopic Internal Standards: Stable isotope-labeled analogs (e.g., ¹³C-PC 16:0/18:1) mitigate matrix effects and instrumental drift.
• Calibration Rigor: Linearity validation (R² > 0.99) ensures accurate absolute quantification through multi-point calibration curves.

Workflow Development

• Target Selection: Prioritize lipids (e.g., phosphatidylcholines, sphingomyelins) based on biological relevance.
• Parameter Optimization: Collision energy (e.g., 30 eV) and ion transitions are refined using reference standards.
• Sample Pretreatment: Solid-phase extraction (SPE) enriches target lipids while reducing matrix complexity.

Data Acquisition and Validation

• Internal Standard Quantification: Isotope-labeled internal standards (e.g., PE 16:0/18:1) normalize analyte signals.
• Quality Assurance: Recovery rates (80–120%) and precision (CV < 15%) are validated via quality control (QC) samples.

Key Challenges

• Standard Dependency: Undetectable novel lipids (e.g., uncharacterized sphingolipids) due to reliance on existing reference materials.
• Cost Constraints: Limited availability and high expense of specialized standards (e.g., isotopically labeled eicosanoids).
• Matrix Effects: Ion suppression from co-eluting phospholipids in complex samples (e.g., plasma) necessitates advanced purification strategies.

Comparison of Technical Principles: Untargeted vs. Targeted Lipidomics

Data analysis and comparison

Untargeted Lipidomics

Data Processing Pipeline

• Feature Detection and Alignment
  • Tools: XCMS Online, Proteome Discoverer, El-MAVEN.
  • Key Steps:
    • Chromatographic Alignment: Compensates for retention time variability (e.g., ±0.1 min tolerance) arising from inter-sample chromatographic variability.
    • Mass Accuracy Correction: Utilizes reference standards (e.g., perfluorotributylamine) to minimize mass drift (<5 ppm error).
    • Peak Integration: Extracts ion chromatogram peak areas while suppressing noise via algorithms like Savitzky-Golay smoothing.

Structural Elucidation

• Multi-Tier Annotation:
  • Class-Level: Categorized by polar headgroup classification (e.g., phosphatidylcholines, triglycerides).
  • Subclass-Level: Differentiated by acyl chain composition (saturated, monounsaturated, polyunsaturated).
  • Molecular Species: Determined via precursor ion mass (e.g., m/z 780.6 for PC 16:0/18:1) and fragmentation patterns (e.g., m/z 184 for PC headgroups).
• Isomer Resolution:
  • Positional Isomers: Distinguished using high-resolution MS and collision cross-section (CCS) databases.
  • Structural Isomers: Resolved via hydrophilic interaction liquid chromatography (HILIC).

Statistical Exploration

• Differential Analysis: Significance thresholds (fold change >2, adjusted p<0.05) coupled with multivariate methods (PCA, PLS-DA) for biomarker discovery.
• Pathway Mapping: Metabolic pathway analysis via KEGG/Reactome, focusing on lipid-centric pathways (e.g., sphingolipid metabolism).
• Network Modeling: Cytoscape-based integration of lipid-metabolite-gene interactions (e.g., lipid raft protein associations).

Advanced Analytical Tools

• MetaboAnalyst 5.0
  • Functionality: Enables data standardization (log transformation, normalization), pathway enrichment (KEGG, WikiPathways), and automated generation of visual analytics (volcano plots, heatmaps).
• LipidHome
  • Machine Learning Integration: Employs algorithms (random forests, SVMs) to predict novel lipid structures, enhanced by cross-referencing with LipidMaps.
• LipidMatch
  • Open-Source Platform: Annotates lipid subclasses via diagnostic fragment ions (e.g., Δm/z 24 indicating CH₂ group loss).

Challenges and Mitigation Strategies

• Low-Abundance Lipid Detection
  • Solution: Microfluidic-based preconcentration (e.g., Agilent 1290 UHPLC) to enhance sensitivity.
• Annotation Ambiguity
  • Solution: Multi-database consensus validation (LipidMaps, HMDB, PubChem) retaining only high-confidence annotations (>70% confidence).
• Batch Effects
  • Solution: Batch effect mitigation using the ComBat algorithm (R package sva) to harmonize inter-run variability.

Targeted Lipidomics

Quantitative Methodologies

• Internal Standardization and Calibration
  • Isotopic Internal Standards: Deuterium-labeled analogs (e.g., ²H-PE 16:0/18:1) mitigate matrix effects and instrumental variations.
  • Calibration Curves: Linear regression models (R² > 0.99) across concentration gradients (1 pg/mL–1 µg/mL) enable absolute quantification.
• Dynamic Range Enhancement
  • Segmented MRM: Adjust scanning parameters for analytes spanning wide abundance ranges (e.g., low-concentration eicosanoids vs. abundant triglycerides).
  • Ion Mobility Spectrometry (IMS): Resolves isobaric species (e.g., PC 18:1(9Z) vs. PC 18:1(11Z)) via differential mobility.

Targeted lipidomics data were grouped by lipid class (Mohamed A et al., 2020).

Analytical Validation

• Method Performance Metrics
  • Linearity and Sensitivity: Achieves quantification limits as low as femtogram-per-milliliter (LLOQ) with R² > 0.99.
  • Precision and Recovery: Intra-batch coefficient of variation (CV) <15% and recovery rates of 80–120%, validated against reference materials (e.g., NIST SRM 1950).
• Multi-Center Reproducibility
  • Cross-Platform Consistency: Inter-laboratory validation (e.g., LC-MS/MS vs. CE-MS) ensures <10% relative standard deviation (RSD).
  • Sample Stability: Assess lipid integrity under freeze-thaw cycles (-80°C to RT) and short-term storage (4°C).

Tools and Regulatory Compliance

• Software Solutions
  • Skyline: Open-source platform for SRM/MRM method design, internal standard integration, and data export.
  • MultiQuant®: Commercial software for peak alignment, multi-reaction monitoring, and automated reporting.
• Regulatory Standards
  • FDA 21 CFR Part 11: Ensures data integrity through audit trails and electronic signatures for traceability.

Challenges and Mitigation

• Matrix Interference
  • SPE/Dilution: Solid-phase extraction or sample dilution reduces ion suppression from co-eluting compounds.
• Standard Availability
  • Synthetic Standards: Develop ¹³C/¹⁵N-labeled lipids or structure-based predictive models (e.g., Q-TOF MS).
• Dynamic Range Limitations
  • Online Dilution: Coupled with segmented MRM to extend detectable concentration ranges.

Comparison of Data Analysis: Untargeted vs. Targeted Lipidomics

Application Comparison

Untargeted Lipidomics

Study on disease mechanism

• Metabolic Reprogramming in Hepatic Carcinoma: Hepatocellular carcinoma (HCC) exhibits dysregulated accumulation of lysophosphatidylcholine (LPC), implicating its role as an oncogenic signaling molecule. e.g., This study addressed HCC's metabolic heterogeneity by integrating transcriptomic, metabolomic, and lipidomic datasets to delineate reprogrammed pathways, including altered glucose utilization, lipid catabolism, and de novo lipogenesis. Lipidomic profiling revealed pronounced perturbations in glycerolipids, phosphatidylcholines, and sphingolipid derivatives. Machine learning algorithms identified lipid metabolism-associated genes as universal HCC biomarkers across etiologies. Experimental validation demonstrated that pharmacologically inhibiting LPCAT1 and ceramide synthase 5 (CERS5)—key enzymes in phosphatidylcholine biosynthesis—effectively suppressed HCC progression. Notably, CERS5 drives tumorigenesis by enhancing lipid scavenging, offering novel avenues for metabolic-targeted therapies and prognostic biomarker development (Liu Q et al., 2025).
• Sphingolipid Dysregulation in AD: Reductions in plasma sphingomyelin levels correlate with cognitive decline severity in AD. e.g., A pioneering multidimensional mass spectrometry analysis of 26 AD patients and 26 cognitively normal controls mapped systemic sphingolipid network alterations. AD cohorts exhibited diminished long-chain acyl-sphingolipids (e.g., C22:0, C24:0) and elevated ceramide species (N16:0, N21:0), with these shifts linked to Mini-Mental State Examination (MMSE) scores and apolipoprotein E4 (ApoE4) genotype. This inverse sphingolipid-ceramide relationship underscores a metabolic imbalance in AD pathogenesis, proposing peripheral sphingolipid signatures as tools for early diagnosis and disease staging (Han X et al., 2011).

Environmental Toxicology

• Pesticide exposure: Lipid peroxidation emerges as a key pathway of cellular injury following pesticide exposure. e.g., This investigation employed an integrative lipidomic-metabolomic strategy to elucidate the neurotoxic effects of neonicotinoid insecticides (imidacloprid, acetamiprid) on Neuro-2a cells. Dose-response assessments determined half-maximal inhibitory concentrations (IC50: imidacloprid = 1152.1 μM; acetamiprid = 936.5 μM), with subtoxic acetamiprid doses (IC10/IC20) inducing pronounced lipid metabolic dysregulation. Triglycerides (TGs), phosphatidylcholines (PCs; 25.9% of total lipids), and diglycerides exhibited marked perturbations. Multivariate analysis identified 14 dysregulated lipid species and 40 perturbed metabolites, implicating disruptions in glycerophospholipid, sphingolipid, and glutathione pathways. These findings demonstrate that both insecticides exacerbate cellular toxicity by disrupting lipid metabolic homeostasis, offering novel multi-omics insights into their neurotoxic mechanisms and environmental risk profiles (Wang X et al., 2021).
• Crop stress resistance: Untargeted lipidomic approaches enable comprehensive profiling of lipid remodeling during plant stress responses. e.g., This study contrasted lipidomic signatures of drought-tolerant (Thymus serpyllum) and drought-sensitive (Thymus vulgaris) thyme under water deficit. Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) quantified a 55% reduction in galactolipid and phospholipid levels in drought-sensitive plants, while stress-resilient specimens retained signaling lipids (e.g., oxylipins at m/z 519.3331, 521.3488, 581.3709) despite 50–60% declines. Partial least squares-discriminant analysis (PLS-DA) classified samples into four distinct groups: tolerant-control, tolerant-stress, sensitive-control, and sensitive-stress, highlighting coordinated lipidomic and morphophysiological adaptations as central to drought resilience. These results underscore lipid metabolic plasticity as a critical determinant of plant stress survival strategies (Moradi P et al., 2011).

Targeted Lipidomics

Verification of clinical diagnostic markers

• Cardiovascular diseases: The development of lipidomics technology makes the detection of trace lipid molecules such as ceramide more accurate, which provides new possibilities for early warning of cardiovascular diseases. e.g., In this study, liquid chromatography-mass spectrometry (LC-MS) analysis of three independent cohorts (WECAC, LIPID and KAROLA) confirmed for the first time that ceramide combined with phosphatidylcholine (PC) as a biomarker can significantly improve the predictive efficacy of cardiovascular death risk in patients with atherosclerotic coronary heart disease. The composite risk score based on WECAC (including specific ceramide and PC combination) showed strong correlation in all three cohorts (HR=1.44-1.69), and the predictive power was further improved after combining with high-sensitivity troponin T (HR of WECAC and KAROLA reached 1.63 and 2.04 respectively). The C statistic of the score in predicting CVD death is 0.76, and its performance is comparable to the existing secondary prevention model, which provides a new risk assessment tool with both biological mechanism and clinical practicability for clinic (Hilvo M et al., 2021).
• Children's metabolic disorder: It reveals the adjustable cardiovascular metabolic risk characteristics of obese children and adolescents, and provides a new perspective for obesity management. e.g., This study revealed the correlation between obesity in children and lipid markers of cardiac metabolic risk through cross-sectional proteomic analysis: the level of ceramide in peripheral blood of overweight/obese children increased, while lysophospholipids and ω-3 fatty acids decreased, among which ceramide, phosphatidylethanolamine and phosphatidylinositol were positively correlated with insulin resistance, while sphingomyelin was negatively correlated. The combination of three lipids can effectively predict hepatic steatosis (the efficacy is equivalent to liver enzyme index), and lipid spectrum mediates the correlation between obesity and metabolic characteristics. Further non-drug intervention (such as weight loss program) confirmed that reducing the degree of obesity can significantly reduce the levels of ceramide, phospholipid and triglyceride, which provided evidence-based for lipid-targeted intervention of obesity-related metabolic disorders in children (Huang Y et al., 2025).

Pharmacokinetics

• Statins: monitor the changes of ceramide composition in patients' serum and evaluate the drug effect. e.g., In this study, the concentration changes of four ceramides (Cer d18:1/16:0, d18:1/18:0, d18:1/24:1, d18:1/24:0) in 110 patients with acute coronary syndrome (ACS) were dynamically monitored by targeted lipid proteomics analysis (HPLC-MS/MS). All ceramides reached the peak at the time of admission, and then decreased on the third day of admission and 3 months of follow-up. The difference between Cer d18:1/18:0 concentration and its baseline value 3 months after discharge is independently related to cardiovascular recurrence (not related to statin treatment), and the relationship between the change of Cer d18:1/18:0 from admission to the third day and prognosis is regulated by blood sugar status. This shows that dynamic monitoring of specific ceramide subtypes can provide metabolic basis for stratified recurrence risk and individualized intervention for ACS patients (Usova E et al., 2024).

Food safety inspection

• Trans fatty acids: EU regulations require that the content of trans fatty acids in food should be less than 0.5%, and targeted methods can be used for accurate detection. e.g., In this study, a targeted proteomics method (LC-MS/MS) was developed to quantitatively analyze 35 active carbonyl species (RCS) produced by lipid peroxidation in fish oil, including acrolein, HHE, HNE, etc. High sensitivity detection was achieved by Fe(II)-mediated oxidation combined with DNPH derivatization and SPE purification. It was found that there was a significant difference between the carbonyl compounds of omega-3 and omega-6 fatty acids. The method was successfully applied to the oxidation monitoring of 10 fish oil products after verification, and the correlation between analytes and parent fatty acids was confirmed by Pearson correlation. This technology provides an accurate analytical tool for the study of lipid peroxidation mechanism and the evaluation of functional oil quality (Suh JH et al., 2017).

Joint Application

• Food flavor: To detect the formation mechanism of food flavor and improve the curing method of food. e.g., This study employed an integrated targeted and non-targeted metabolomic approach to elucidate flavor development mechanisms in salted bass. Elevated salinity accelerated the breakdown and oxidative modification of phosphatidylcholine (PC) and phosphatidylethanolamine (PE), which constituted 40.12% of total lipids, while concurrently driving the notable accumulation of key volatile flavor compounds, including 1-octen-3-ol and 2-undecanone. Furthermore, metabolites such as glycine and succinic acid were identified as synergistic enhancers of umami and saltiness perception. By mapping lipid metabolic networks, the research demonstrated that salt modulates biochemical pathways to harmonize flavor enrichment with mitigation of lipid oxidation-derived health risks. These insights establish a theoretical framework for refining traditional fish-salting practices through precision control of lipid dynamics (Zhang ZC et al., 2025).
• Metabolic diseases: exploring the effects of dietary lipids on diseases. e.g., In this study, C57Bl/6 mice were intervened by long-term high-fat diet (OBD) and control diet (CON), and the interaction mechanism of diet-flora-lipid metabolism-liver inflammation was revealed: OBD significantly changed intestinal flora (Firmicutes and Bacteroides), induced the accumulation of omega-6 fatty acids (arachidonic acid), decreased omega-3 lipid mediators and liver inflammation (ALT/L). It is worth noting that after the OBD-R group resumed CON diet, the flora disorder and lipid inflammatory markers were partially reversed, which confirmed that dietary intervention could dynamically adjust metabolic adaptability. This study clarifies that diet-induced chronic inflammation can be alleviated by adjusting diet structure, which provides a theoretical basis for lifestyle intervention of metabolic diseases (Upadhyay G et al., 2024).
• Target development: develop the target of diabetes diagnosis through joint analysis. e.g., In this study, serum samples of 155 subjects were analyzed by LC-MS, and the dynamic changes of lipid metabolism in different stages of T2DM were revealed: 44 lipid metabolites in newly diagnosed patients were significantly abnormal, and 29 lipid changes in high-risk individuals involved in sphingomyelin, phosphatidylcholine and sterol ester metabolism disorder, suggesting the mechanism of insulin resistance and oxidative stress. Thirteen lipid markers with diagnostic potential were also identified, and their levels fluctuated regularly with the progress of the disease, which provided a new target for early diagnosis and treatment strategy development of T2DM (Feng L et al., 2024).

Comparative Analysis of Untargeted and Targeted Lipidomics Approaches

Shared Methodological Frameworks

Both strategies employ chromatographic separation coupled with mass spectrometry (e.g., LC-MS, GC-MS) as foundational platforms to resolve lipid species, leveraging mass analyzers for molecular identification. Critical operational parameters—such as ionization source settings (e.g., electrospray voltage, collision energy)—require optimization to maximize sensitivity and specificity.

Sample Preparation Protocols

Lipid enrichment is achieved via organic solvent-based extraction (e.g., Folch or Bligh-Dyer protocols), effectively isolating lipids while removing non-lipid contaminants like proteins and carbohydrates. Rigorous quality control (QC) measures, including replicate injections of pooled samples, ensure technical reproducibility and data robustness.

Data Processing Commonalities

• Spectral Feature Processing: Involves peak picking, alignment, noise reduction, and normalization (e.g., total ion current or internal standard-based approaches).
• Statistical Workflows: Multivariate statistical approaches (e.g., PCA, PLS-DA) identify inter-group lipidomic differences, though targeted workflows prioritize quantitative validation of predefined lipid panels.

Biological and Functional Objectives

Both approaches aim to elucidate lipid metabolic networks in pathological conditions (e.g., cancer, metabolic syndrome) or physiological states, uncovering regulatory mechanisms. Functional interpretation relies on lipid-centric databases (e.g., LIPID MAPS, KEGG) to map pathways and annotate biological relevance.

Standardization and Quality Assurance

• Calibration: Isotopically labeled standards (e.g., d7-cholesterol) compensate for extraction efficiency variability and instrumental response biases.
• Guideline Adherence: Compliance with community-endorsed protocols (e.g., Lipidomics Standards Initiative) ensures cross-study comparability and data integrity.

References

1. Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J, Du H, Zhang N, Zhao J, Zhang Y, Wang L, Wei Y, Liu C, Qian R, Xiang L, Li W, Xiu P, Ma C, Yu Y, Jiang S. "Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC." Hepatology. 2025 Apr 1;81(4):1164-1180. doi: 10.1097/HEP.0000000000000962
2. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, Welsh-Bohmer KA, Doraiswamy PM, Kaddurah-Daouk R. "Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics." PLoS One. 2011;6(7):e21643. doi: 10.1371/journal.pone.0021643
3. Wang X, Qiu J, Xu Y, Liao G, Jia Q, Pan Y, Wang T, Qian Y. "Integrated non-targeted lipidomics and metabolomics analyses for fluctuations of neonicotinoids imidacloprid and acetamiprid on Neuro-2a cells." Environ Pollut. 2021 Sep 1;284:117327. doi: 10.1016/j.envpol.2021.117327
4. Moradi P, Mahdavi A, Khoshkam M, Iriti M. "Lipidomics Unravels the Role of Leaf Lipids in Thyme Plant Response to Drought Stress." Int J Mol Sci. 2017 Sep 28;18(10):2067. doi: 10.3390/ijms18102067
5. Hilvo M, Meikle PJ, Pedersen ER, Tell GS, Dhar I, Brenner H, Schöttker B, Lääperi M, Kauhanen D, Koistinen KM, Jylhä A, Huynh K, Mellett NA, Tonkin AM, Sullivan DR, Simes J, Nestel P, Koenig W, Rothenbacher D, Nygård O, Laaksonen R. "Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients." Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387
6. Huang Y, Sulek K, Stinson SE, Holm LA, Kim M, Trost K, Hooshmand K, Lund MAV, Fonvig CE, Juel HB, Nielsen T, Ängquist L, Rossing P, Thiele M, Krag A, Holm JC, Legido-Quigley C, Hansen T. "Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity." Nat Med. 2025 Jan;31(1):294-305. doi: 10.1038/s41591-024-03279-x
7. Usova E, Yakovlev A, Kopanitsa G, Metsker O, Alieva M, Makarova T, Malishevskii L, Murashko E, Kessenikh E, Trusov S, Alieva A, Konradi A. "Prognostic Value of Ceramide Dynamics in Patients with Acute Coronary Syndrome." Stud Health Technol Inform. 2024 Nov 22;321:175-179. doi: 10.3233/SHTI241087
8. Suh JH, Niu YS, Hung WL, Ho CT, Wang Y. "Lipidomic analysis for carbonyl species derived from fish oil using liquid chromatography-tandem mass spectrometry." Talanta. 2017 Jun 1;168:31-42. doi: 10.1016/j.talanta.2017.03.023
9. Zhang ZC, Wang J, Dong M, Cui S, Huang XH, Qin L. "Integration of untargeted lipidomics and targeted metabolomics revealed the mechanism of flavor formation in lightly cured sea bass driven via salt." Food Chem. 2025 Apr 1;470:142675. doi: 10.1016/j.foodchem.2024.142675
10. Upadhyay G, Gowda SGB, Mishra SP, Nath LR, James A, Kulkarni A, Srikant Y, Upendram R, Marimuthu M, Hui SP, Jain S, Vasundhara K, Yadav H, Halade GV. "Targeted and untargeted lipidomics with integration of liver dynamics and microbiome after dietary reversal of obesogenic diet targeting inflammation-resolution signaling in aging mice." Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Dec;1869(8):159542. doi: 10.1016/j.bbalip.2024.159542
11. Feng L, He B, Xia J, Wang Z. "Untargeted and Targeted Lipidomics Unveil Dynamic Lipid Metabolism Alterations in Type 2 Diabetes." Metabolites. 2024 Nov 10;14(11):610. doi: 10.3390/metabo14110610